Cassava Sciences Inc (SAVA)
19.72
-0.17
(-0.85%)
USD |
NASDAQ |
Jun 14, 16:00
19.74
+0.02
(+0.10%)
After-Hours: 20:00
Cassava Sciences Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
September 30, 2006 | 2.596M |
June 30, 2006 | 6.305M |
March 31, 2006 | 4.234M |
December 31, 2005 | 0.889M |
September 30, 2005 | |
June 30, 2005 | |
March 31, 2005 | 91.03M |
December 31, 2004 | |
September 30, 2004 | |
June 30, 2004 | |
March 31, 2004 | |
December 31, 2003 | 65.40M |
Date | Value |
---|---|
September 30, 2003 | |
June 30, 2003 | 0.038M |
March 31, 2003 | |
December 31, 2002 | 0.055M |
September 30, 2002 | |
June 30, 2002 | 0.0829M |
March 31, 2002 | |
December 31, 2001 | 0.117M |
September 30, 2001 | |
June 30, 2001 | |
March 31, 2001 | |
December 31, 2000 | 0.4453M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
Amylyx Pharmaceuticals Inc | 20.35M |
ACADIA Pharmaceuticals Inc | 94.70M |
Vertex Pharmaceuticals Inc | 1.793B |
Cormedix Inc | -- |
Oragenics Inc | -- |